Harris Williams Advises Medical Knowledge Group, LLC on its Sale to Novo Holdings A/S

Rhea-AI Summary

Harris Williams has advised Medical Knowledge Group (MKG) on its sale to Novo Holdings. MKG is a leading analytics-driven commercialization platform that enhances biopharmaceutical brands' clinical and commercial potential. This transaction highlights the growth in the outsourced pharmaceutical services sector, indicating a robust demand for analytical solutions. Court Square Capital Partners and Aisling Capital were previous investors in MKG, which serves various clients from biotech firms to major pharmaceutical companies. The acquisition aims to leverage MKG's capabilities for sustained market growth.

Positive

• MKG's sale to Novo Holdings emphasizes its strong market position in pharmaceutical analytics services.
• The acquisition is expected to fuel MKG's growth and innovation capabilities in the pharma sector.
• The outsourced pharmaceutical services market is experiencing strong growth, offering favorable conditions for MKG.

Negative

• None.

RICHMOND, Va.--(BUSINESS WIRE)-- Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised Medical Knowledge Group, LLC (MKG), a portfolio company of Court Square Capital Partners (Court Square) and Aisling Capital (Aisling), on its sale to Novo Holdings A/S (Novo Holdings). MKG is an analytics-driven commercialization platform delivering healthcare provider targeted insights and solutions that maximize the clinical and commercial potential of biopharmaceutical customer brands. The transaction was led by Paul Hepper, Brian Jones, and Hampton Cokeley of the Harris Williams Healthcare & Life Sciences (HCLS) Group and Dan Linsalata of the firm’s Technology Group.

“The MKG team has done a tremendous job building a premier analytics-driven commercialization services platform with truly differentiated capabilities and solutions in one of the most attractive sectors of outsourced pharmaceutical services,” said Paul Hepper, a managing director at Harris Williams. “It was a pleasure working with the teams at MKG and Court Square on this transaction and we believe the company has found a fantastic new partner in Novo Holdings.”

“The outsourced pharma commercialization services market continues to experience strong growth as biopharmaceutical firms increasingly recognize the value proposition of firms that can utilize differentiated analytics tools to drive outsized results in their commercialization solutions,” said Dan Linsalata, a managing director at Harris Williams. “Differentiated platforms like MKG will continue to benefit disproportionately from the market tailwinds in the sector and we look forward to seeing the company’s continued success and growth in partnership with Novo Holdings.”

MKG is a New York-based, independent analytics-driven and technology-enabled multi-channel marketing solutions provider serving marketing, medical affairs, and stakeholder relations teams at biopharmaceutical companies throughout the entire product lifecycle. MKG has a diverse roster of clients ranging from niche biotech and diagnostic companies to some of the world's largest companies in the industry. The company is an analytics-centric, strategic marketing solutions provider that partners with clients to translate the complex science and data behind their brands into market shaping strategies that maximize their clinical and commercial potential.

Court Square is a middle market private equity firm with one of the most experienced investment teams in the industry. Since 1979, Court Square has completed over 240 platform investments, helping managers, families and founder-owners to develop their companies into leaders in their respective markets. Court Square invests in companies that have compelling growth potential in the business services, industrial, healthcare, and tech and telecom sectors. Court Square has $7.5 billion of assets under management and is based in New York.

Aisling is a leading life sciences investment firm that invests in products, technologies and global businesses that advance human health. Since 2000, Aisling has raised over $2 billion across five funds. The Aisling team’s combination of clinical, operational and financial experience allows the firm to partner with entrepreneurs to identify, execute and realize investments utilizing a variety of structures across the life sciences industry.

Novo Holdings is a private limited liability company wholly owned by the Novo Nordisk Foundation. It is the holding company of the Novo Group, comprising Novo Nordisk A/S and Novozymes A/S, and is responsible for managing the Novo Nordisk Foundation’s assets. Novo Holdings is recognized as a leading international life science investor, with a focus on creating long-term value. As a life science investor, Novo Holdings provides seed and venture capital to development-stage companies and takes significant ownership positions in growth and well-established companies. Novo Holdings also manages a broad portfolio of diversified financial assets.

Harris Williams, an investment bank specializing in M&A advisory services, advocates for sellers and buyers of companies worldwide through critical milestones and provides thoughtful advice during the lives of their businesses. By collaborating as one firm across Industry Groups and geographies, the firm helps its clients achieve outcomes that support their objectives and strategically create value. Harris Williams is committed to execution excellence and to building enduring, valued relationships that are based on mutual trust. Harris Williams is a subsidiary of the PNC Financial Services Group, Inc. (NYSE: PNC).

The Harris Williams HCLS Group has experience across a broad range of sectors, including healthcare providers; payors and payor services; outsourced pharmaceutical services; medical device supply chain; healthcare IT; and pharmacy. For more information on the HCLS Group and other recent transactions, visit the HCLS Group’s section of the Harris Williams website.

The Harris Williams Technology Group advises leading private and public companies, founders, and private equity, growth equity and venture capital firms on mergers and acquisitions and capital-raising transactions worldwide. The Technology Group has deep domain expertise in software and technology-enabled services and dedicated focus areas across a variety of vertical software applications and end markets. For more information on the Technology Group and its recent transactions, visit the Technology Group’s section of the Harris Williams website.

Harris Williams LLC is a registered broker-dealer and member of FINRA and SIPC. Harris Williams & Co. Ltd is a private limited company incorporated under English law with its registered office at 8th Floor, 20 Farringdon Street, London EC4A 4AB, UK, registered with the Registrar of Companies for England and Wales (registration number 07078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co. Corporate Finance Advisors GmbH is registered in the commercial register of the local court of Frankfurt am Main, Germany, under HRB 107540. The registered address is Bockenheimer Landstrasse 33-35, 60325 Frankfurt am Main, Germany (email address: hwgermany@harriswilliams.com). Geschäftsführer/Directors: Jeffery H. Perkins, Paul Poggi. (VAT No. DE321666994). Harris Williams is a trade name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH conduct business.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220202005678/en/

For media inquiries, please contact Julia Moore at media@harriswilliams.com.

Source: Harris Williams LLC

FAQ

What is the recent acquisition involving PNC and Medical Knowledge Group?

Harris Williams advised Medical Knowledge Group (MKG) on its sale to Novo Holdings, enhancing MKG's position in the pharmaceutical services market.

Who were the investors in Medical Knowledge Group before the sale to Novo Holdings?

Before the sale, Medical Knowledge Group was backed by Court Square Capital Partners and Aisling Capital.

What services does Medical Knowledge Group provide?

Medical Knowledge Group provides analytics-driven commercialization services for biopharmaceutical companies, maximizing brand potential throughout the product lifecycle.

Why is the acquisition of Medical Knowledge Group significant?

The acquisition is significant as it reflects the increasing demand for data-driven solutions in the rapidly growing outsourced pharmaceutical services market.

What role does Harris Williams play in the recent transaction involving MKG?

Harris Williams acted as the advisor for Medical Knowledge Group during its sale to Novo Holdings, facilitating the transaction.